World Evidence, Pricing and Access (World EPA) Congress 2026 brought together market access leaders, HTA experts, policymakers and industry stakeholders in Amsterdam to discuss how evidence, pricing strategy and access planning are evolving in today’s complex policy environment.
Across two days, sessions explored the practical realities facing Market Access and HEOR teams, from early evidence planning and HTA engagement to evolving approaches for managing affordability and access to innovative therapies.
The Remap Consulting team joined discussions across the programme and contributed new research examining how emerging treatment pathways may influence patient behaviour and access dynamics.
To support Market Access and HEOR teams navigating these developments, we’ve brought together:
- Our World EPA 2026 research poster, presented at the congress
- A concise downloadable summary combining key insights and themes from Day 1 and Day 2 of the event
Research Poster
Our team presented a research poster examining how new access routes for obesity medicines may influence treatment pathways and patient behaviour.
“Private versus public access: Exploring how obesity medicines may influence treatment pathways and patient behaviour”
This research explores how increasing availability of obesity medicines through private healthcare channels may affect patient pathways, treatment initiation and demand for public reimbursement.
The analysis considers how private access could influence treatment sequencing, patient expectations and payer decision-making, highlighting potential implications for future access strategies.
Access the research poster here
Download the Full World EPA 2026 Summary
Our World EPA 2026 summary brings together the most important insights and discussions from across the congress, combining our Day 1 and Day 2 coverage into a single, concise document.
Inside, you’ll find highlights on:
- Key themes shaping discussions across the World EPA programme
- Emerging considerations for evidence generation and access strategy
- Perspectives shared across sessions relevant to Market Access and HEOR teams
Download the full summary here